IGMS - IGM Biosciences GAAP EPS of -$1.32 beats by $0.13 revenue of $0.33M beats by $0.07M
- IGM Biosciences press release ( NASDAQ: IGMS ): Q3 GAAP EPS of -$1.32 beats by $0.13 .
- Revenue of $0.33M beats by $0.07M .
- Cash and investments as of September 30, 2022 were $469.1 million, compared to $229.5 million as of December 31, 2021.
For further details see:
IGM Biosciences GAAP EPS of -$1.32 beats by $0.13, revenue of $0.33M beats by $0.07M